Β-caryophyllene is available orally and acts via CB2 and PPARγ to limit colitis.102 Similarly, αβ-amyrin ameliorates both TNBS103 and DSS104 colitis and acts, at least in part, through cannabinoid receptors. Here, CNR2 is linked to colitis.